2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$103.51-$0.12 (-0.12%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.5BMarket Cap
- 314.52%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$103.51-$0.12 (-0.12%)
INBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $103.63 | ||
Change | +$4.48 (+4.52%) | ||
Open | $100.76 | ||
High | $105.65 | ||
Low | $99.05 | ||
Previous Close | $99.15 | ||
Volume | 220,744 | ||
30-Day Average Volume | 227,020 | ||
1-Week Change | 17.27% | ||
1-Month Change | 18.29% | ||
1-Year Change | 314.52% | ||
3-Year Change | 447.44% | ||
5-Year Change | 264.13% | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $154.2M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$36.6M | ||
Free Cash Flow | -$29.9M | ||
EBIT | -$30.9M | ||
EBITDA | -$30.4M | ||
Net Working Capital | $114.1M | ||
EPS | -$2.34 | ||
Enterprise Value/EBITDA | -52 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -29 | ||
P/E | -44 | ||
PEG | 5 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue